Literature DB >> 18413417

Clinical and laboratory characteristics of Finnish lupus erythematosus patients with cutaneous manifestations.

S Koskenmies1, T M Järvinen, P Onkamo, J Panelius, U Tuovinen, T Hasan, A Ranki, U Saarialho-Kere.   

Abstract

Our objective was to characterize clinical features, laboratory findings, concomitant autoimmune diseases, and smoking habits of lupus erythematosus subgroups in genetically homogeneous patients from two Dermatology Departments of Finnish University hospitals. One hundred and seventy eight discoid lupus erythematosus, 55 subacute cutaneous lupus erythematosus, and 77 systemic lupus erythematosus patients were enrolled using patients' charts from institutional database (1995-2006) and during routine control visits. Clustering analysis was performed to reveal natural groupings. Smoking at the onset of disease was significantly more common in all subgroups (57% for discoid lupus erythematosus, 35% for subacute cutaneous lupus erythematosus, and 34% for systemic lupus erythematosus) compared with the age/gender-matched prevalence in the Finnish population, suggesting smoking to be a trigger factor for cutaneous lupus. Leukopenia (38%) and lymphopenia (52%) were observed more often in patients with systemic lupus erythematosus than reported previously. Photosensitivity characterized all groups, especially patients with subacute cutaneous lupus erythematosus (87%). Of the autoimmune diseases, Sjögren's syndrome was the most common (22% of patients with systemic lupus erythematosus), followed by autoimmune thyroid disease (13% of patients with subacute cutaneous lupus erythematosus). The clustering analysis showed environmental factors (smoking) to be more involved in disease development in discoid lupus erythematosus, whereas immunological factors were more significant in initiating systemic lupus erythematosus. The high prevalence of autoimmune thyroid disease, together with photosensitivity, and the clustering profiles suggest that lupus erythematosus subtypes, especially discoid lupus erythematosus, are heterogeneic in their pathomechanisms.

Entities:  

Mesh:

Year:  2008        PMID: 18413417     DOI: 10.1177/0961203307087403

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  12 in total

1.  Patient Perspectives on Smoking Cessation and Interventions in Rheumatology Clinics.

Authors:  Aimée Wattiaux; Brittany Bettendorf; Laura Block; Andrea Gilmore-Bykovskyi; Edmond Ramly; Megan E Piper; Ann Rosenthal; Jane Sadusky; Elizabeth Cox; Betty Chewning; Christie M Bartels
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-03       Impact factor: 4.794

2.  Impact of smoking in cutaneous lupus erythematosus.

Authors:  Evan W Piette; Kristen P Foering; Aileen Y Chang; Joyce Okawa; Thomas R Ten Have; Rui Feng; Victoria P Werth
Journal:  Arch Dermatol       Date:  2011-11-21

3.  Cigarette smoking and response to antimalarials in cutaneous lupus erythematosus patients: evolution of a dogma.

Authors:  Jan Dutz; Victoria P Werth
Journal:  J Invest Dermatol       Date:  2011-10       Impact factor: 8.551

4.  Association of discoid lupus erythematosus with clinical manifestations and damage accrual in a multiethnic lupus cohort.

Authors:  Yesenia Santiago-Casas; Luis M Vilá; Gerald McGwin; Ryan S Cantor; Michelle Petri; Rosalind Ramsey-Goldman; John D Reveille; Robert P Kimberly; Graciela S Alarcón; Elizabeth E Brown
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-05       Impact factor: 4.794

5.  Cancer risk in cutaneous lupus erythematosus: a population-based cohort study.

Authors:  Abha G Singh; Cynthia S Crowson; Siddharth Singh; Mark Denis P Davis; Hilal Maradit-Kremers; Eric L Matteson; Vaidehi R Chowdhary
Journal:  Rheumatology (Oxford)       Date:  2016-08-12       Impact factor: 7.580

6.  Identification of MAMDC1 as a candidate susceptibility gene for systemic lupus erythematosus (SLE).

Authors:  Anna Hellquist; Marco Zucchelli; Cecilia M Lindgren; Ulpu Saarialho-Kere; Tiina M Järvinen; Sari Koskenmies; Heikki Julkunen; Päivi Onkamo; Tiina Skoog; Jaana Panelius; Anne Räisänen-Sokolowski; Taina Hasan; Elisabeth Widen; Iva Gunnarson; Elisabet Svenungsson; Leonid Padyukov; Ghazaleh Assadi; Linda Berglind; Ville-Veikko Mäkelä; Katja Kivinen; Andrew Wong; Deborah S Cunningham Graham; Timothy J Vyse; Mauro D'Amato; Juha Kere
Journal:  PLoS One       Date:  2009-12-07       Impact factor: 3.240

7.  MHC class II polymorphism is associated with a canine SLE-related disease complex.

Authors:  Maria Wilbe; Päivi Jokinen; Christina Hermanrud; Lorna J Kennedy; Erling Strandberg; Helene Hansson-Hamlin; Hannes Lohi; Göran Andersson
Journal:  Immunogenetics       Date:  2009-07-28       Impact factor: 2.846

Review 8.  Rheumatic manifestations of skin disease.

Authors:  Jennie T Clarke; Victoria P Werth
Journal:  Curr Opin Rheumatol       Date:  2010-01       Impact factor: 5.006

9.  Genome-wide association mapping identifies multiple loci for a canine SLE-related disease complex.

Authors:  Maria Wilbe; Päivi Jokinen; Katarina Truvé; Eija H Seppala; Elinor K Karlsson; Tara Biagi; Angela Hughes; Danika Bannasch; Göran Andersson; Helene Hansson-Hamlin; Hannes Lohi; Kerstin Lindblad-Toh
Journal:  Nat Genet       Date:  2010-01-31       Impact factor: 38.330

10.  Polymorphisms of the ITGAM gene confer higher risk of discoid cutaneous than of systemic lupus erythematosus.

Authors:  Tiina M Järvinen; Anna Hellquist; Sari Koskenmies; Elisabet Einarsdottir; Jaana Panelius; Taina Hasan; Heikki Julkunen; Leonid Padyukov; Marika Kvarnström; Marie Wahren-Herlenius; Filippa Nyberg; Mauro D'Amato; Juha Kere; Ulpu Saarialho-Kere
Journal:  PLoS One       Date:  2010-12-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.